NCT03793374

Brief Summary

This study included patients who suffered from moderate to severe axillary osmidrosis to receive the modified suction-assisted cartilage shaver, and evaluated the efficacy and complications.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2018

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

December 28, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 7, 2019

Status Verified

January 1, 2019

Enrollment Period

12 months

First QC Date

December 28, 2018

Last Update Submit

January 3, 2019

Conditions

Keywords

Axillary osmidrosisSurgeryCartilage shaver

Outcome Measures

Primary Outcomes (1)

  • The change of malodor of axillary osmidorsis after the modified suction-assiated cartilage shaver

    The efficacy of surgical treatment for axillary osmidrosis is evaluated by the change of the malodor. The degree of malodor is subjective, therefore, the investigators classified the degree of malodor from 1 to 5 to indicate the least severe to the most sever condition. The degree of malodor was recorded before the operation, 1 month after the operation, and 1 year after the operation. The investigators evaluate the efficacy of the surgical treatment by the changes of the degree of the malodor of axillary osmidrosis.

    The treatment efficacy is evaluated 1 year after the surgery.

Secondary Outcomes (1)

  • The rate of complications of the modified suction-assiated cartilage shaver for axillary osmidrosis

    The immediate and longterm complications are recorded and evaluated at 1 week and 1 year respectively after the surgery.

Study Arms (1)

Axillary osmidrosis patients

Patients with axillary malodor and require surgical intervention. The subcutaneous apocrine glands shaving were used.

Other: Subcutaneous apocrine glands shaving

Interventions

A 0.5-cm long incision was made in the identified elliptical surgical area at each axilla for the access of arthroscopy to remove the apocrine glands. A suction-assisted cartilage shaver (E9005 System, Linvatec Corporation, Largo, Florida, USA) was introduced through the incisions to remove of the subcutaneous apocrine glands radially. After defatting, the incisions were closed primarily with 4-0 polyglactin. We anchored the defatting skin to the axillary fascia by 4-0 nylon sutures instead of the tie-over dressing or tissue glues, and we also made several drainage holes by inserting an 18G needle obliquely into the defatting skin. Therefore, draining tubes were no longer needed. We will remove the stiches at the 8th day after the operation.

Axillary osmidrosis patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with axillary osmidrosis and require surgical intervention.

You may qualify if:

  • Patients with moderate to severe axillary osmidrosis and require surgical intervention.

You may not qualify if:

  • Patients with bleeding tendency were excluded.
  • Patients with active infections.
  • Patients with major cardiovascular diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Kaohsiung City, 83301, Taiwan

RECRUITING

Related Publications (5)

  • Yoshikata R, Yanai A, Takei T, Shionome H. Surgical treatment of axillary osmidrosis. Br J Plast Surg. 1990 Jul;43(4):483-5. doi: 10.1016/0007-1226(90)90019-v. No abstract available.

    PMID: 2393776BACKGROUND
  • Wu WH. Ablation of apocrine glands with the use of a suction-assisted cartilage shaver for treatment of axillary osmidrosis: an analysis of 156 cases. Ann Plast Surg. 2009 Mar;62(3):278-83. doi: 10.1097/SAP.0b013e3181776398.

    PMID: 19240525BACKGROUND
  • Chern E, Yau D, Chuang FC, Wu WM. Arthroscopic shaver with refinement for axillary osmidrosis. Int J Dermatol. 2010 Jul;49(7):813-7. doi: 10.1111/j.1365-4632.2010.04540.x.

    PMID: 20618505BACKGROUND
  • Lee JC, Kuo HW, Chen CH, Juan WH, Hong HS, Yang CH. Treatment for axillary osmidrosis with suction-assisted cartilage shaver. Br J Plast Surg. 2005 Mar;58(2):223-7. doi: 10.1016/j.bjps.2004.07.002.

    PMID: 15710118BACKGROUND
  • Tseng YJ, Lee CH, Lin SH. Modified Suction-Assisted Cartilage Shaver for Axillary Osmidrosis. Biomed Res Int. 2019 May 8;2019:7314753. doi: 10.1155/2019/7314753. eCollection 2019.

Study Officials

  • Shang-Hung Lin, M.D.

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Ju Tseng, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician of the Department of Dermatology of Kaohsiung Chang Gung Memorial Hospital

Study Record Dates

First Submitted

December 28, 2018

First Posted

January 4, 2019

Study Start

December 12, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

January 7, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations